Unorganized prostate-specific antigen-based screening for prostate cancer: more harm than benefit. When will we finally start to implement guidelines and risk assessment tools in clinical practice?

Eur Urol. 2015 Sep;68(3):363-4. doi: 10.1016/j.eururo.2015.02.036. Epub 2015 Mar 11.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Early Detection of Cancer / methods*
  • Humans
  • Kallikreins / blood*
  • Male
  • Prostate / pathology*
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / diagnosis*

Substances

  • Kallikreins
  • Prostate-Specific Antigen